News | Cardiovascular Business | February 15, 2022

Leading Cardiology Groups Urge Swift Confirmation of Robert M. Califf

American Heart Association, American College of Cardiology and Association of Black Cardiologists emphasize need for a permanent FDA leader

Robert M. Califf, M.D.

Robert M. Califf, M.D.


February 15, 2022 — The leaders of three of the nation’s leading cardiology groups – American Heart Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA; American College of Cardiology President Dipti Itchhaporia, MD, FACC and Association of Black Cardiologists Michelle A. Albert, MD, MPH – issued the following statement expressing support for the nomination of Robert M. Califf, M.D. as commissioner of the Food and Drug Administration (FDA) and urging a timely Senate confirmation vote:

“Dr. Califf is an accomplished cardiologist, researcher and clinical trials expert who has been a driving force in the fight against heart disease and stroke throughout his career. His extensive experience, combined with his previous leadership of the FDA, will be invaluable as the agency continues to tackle a formidable set of public health challenges.

“As the FDA works to ensure the safety and effectiveness of COVID-19 vaccines, reduce the harm caused by tobacco products, secure food safety, promote good nutrition and streamline the process of drug and device development and review, it requires a permanent leader to oversee these and other critical public health priorities. Dr. Califf is uniquely suited to fill the role of FDA commissioner and manage the agency’s vital efforts to promote public health and reduce the burden of chronic disease.

“We know from experience that Dr. Califf will prioritize science and evidence-based policymaking at the helm of the FDA, just as he has throughout his impressive career. On behalf of the thousands of cardiologists and the millions of cardiovascular disease patients nationwide, we urgently ask the Senate to confirm Dr. Califf with bipartisan support.”

Find more ACC22 content here


Related Content

News | ACC

May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new ...

Home May 09, 2024
Home
News | ACC

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
News | ACC

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

Home April 06, 2024
Home
Feature | ACC | Christine Book

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

Home April 03, 2024
Home
News | ACC

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...

Home March 26, 2024
Home
Feature | ACC | By Melinda Taschetta-Millane

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...

Home March 25, 2024
Home
News | ACC

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...

Home March 21, 2024
Home
News | ACC

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

Home March 07, 2024
Home
News | ACC

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

Home February 29, 2024
Home
News | ACC

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...

Home February 14, 2024
Home
Subscribe Now